7 results
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
monotherapy (2017 AHA/ACC ... anticoagulants (DOACs ... valve (2017 AHA/ACC ... #Management #Cardiology ... #Table #Replacement
Anticoagulation for Atrial Fibrillation - CHA2DS2-VASc

I always tell my students, one of the first thing you
fibrillation in clinic ... practice, CHEST and ACC ... guidelines recommend DOAC ... factor, while ACC ... CHADS2VASC #Score #Management
Single Syringe Adenosine - Instructions
1) Dilute 6-12 mg of adenosine in a syringe for a total
patient's arm Clinical ... to place IV in AC ... #Instructions #pharmacology ... #SVT #cardiology ... #management
Anticoagulant Therapy after PCI (patients with AFib)
Dual-Therapy Preferred:
 • Triple therapy = increased bleeding
due to use of DOAC ... patients in clinical ... Triple #therapy #anticoagulation ... #PCI #pharmacology ... #management #cardiology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Clinical • Under-recognized ... Avoid Warfarin and DOAC ... Delivery • Stable ... suggest prophylactic anticoagulation ... support for patients clinically
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC ... Change in clinical ... Anticoagulation ... indication of AC ... medical and surgical management
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Fraction (HFrEF) Clinical ... → no signs of CXR ... : • ACE Inhibitors ... heartfailure #diagnosis #management ... #cardiology #pharmacology